Cargando…

Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept

Changes in serum cartilage oligomeric matrix protein (COMP) were studied during a 6-month period from initiation of treatment of rheumatoid arthritis patients with either infliximab or etanercept, to elucidate whether the favourable results of tissue protection reported in clinical trials are corrob...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crnkic, Meliha, Månsson, Bengt, Larsson, Lotta, Geborek, Pierre, Heinegård, Dick, Saxne, Tore
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC165057/ https://www.ncbi.nlm.nih.gov/pubmed/12823852 http://dx.doi.org/10.1186/ar760

Ejemplares similares

Serum levels of Cartilage Oligomeric Matrix Protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis
por: Andersson, Maria LE, et al.
Publicado: (2006)

Cardiovascular disease risk in early rheumatoid arthritis: the impact of cartilage oligomeric matrix protein (COMP) and disease activity
por: Rydell, Emil, et al.
Publicado: (2023)

Cartilage oligomeric matrix protein-induced complement activation in systemic sclerosis
por: Otteby, Kaisa E, et al.
Publicado: (2013)

Predictors of infusion reactions during infliximab treatment in patients with arthritis
por: Kapetanovic, Meliha C, et al.
Publicado: (2006)

Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis
por: Crnkic Kapetanovic, Meliha, et al.
Publicado: (2013)

Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden
por: Kristensen, Lars Erik, et al.
Publicado: (2006)

Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs
por: Crnkic Kapetanovic, Meliha, et al.
Publicado: (2013)

Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-α treatment
por: Happonen, Kaisa E, et al.
Publicado: (2012)

Proteomic Analysis of Tendon Extracellular Matrix Reveals Disease Stage-specific Fragmentation and Differential Cleavage of COMP (Cartilage Oligomeric Matrix Protein)
por: Dakin, Stephanie Georgina, et al.
Publicado: (2014)

Circulating complexes between tumour necrosis factor‐alpha and etanercept predict long‐term efficacy of etanercept in juvenile idiopathic arthritis
por: Kahn, Robin, et al.
Publicado: (2016)

Relationship between cartilage oligomeric matrix protein (COMP) and rheumatoid arthritis severity
por: Saghafi, Massoud, et al.
Publicado: (2017)

Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis
por: Andersson, Maria L E, et al.
Publicado: (2013)

Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis
por: Tseng, Susan, et al.
Publicado: (2009)

Cartilage oligomeric matrix protein (COMP) in murine brachiocephalic and carotid atherosclerotic lesions
por: Bond, Andrew R., et al.
Publicado: (2014)

Role of Serum cartilage oligomeric matrix protein (COMP) in the diagnosis of rheumatoid arthritis (RA): A case–control study
por: Liu, Fengxia, et al.
Publicado: (2016)

Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren’s syndrome without disease modifying treatment
por: Nived, Per, et al.
Publicado: (2018)

Immunolocalization of Collagens (I and III) and Cartilage Oligomeric Matrix Protein in the Normal and Injured Equine Superficial Digital Flexor Tendon
por: Södersten, Fredrik, et al.
Publicado: (2013)

Early changes in bone mineral density measured by digital X-ray radiogrammetry predict up to 20 years radiological outcome in rheumatoid arthritis
por: Kapetanovic, Meliha C, et al.
Publicado: (2011)

COMP (Cartilage Oligomeric Matrix Protein) Neoepitope: A Novel Biomarker to Identify Symptomatic Carotid Stenosis
por: Sandstedt, Joakim, et al.
Publicado: (2021)

Disease activity level, remission and response in established rheumatoid arthritis: Performance of various criteria sets in an observational cohort, treated with anti-TNF agents
por: Gülfe, Anders, et al.
Publicado: (2009)

Casual effect of methotrexate+etanercept/infliximab on survival of patients with rheumatoid arthritis
por: Akhlaghi, Saeed, et al.
Publicado: (2019)

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis
por: Kapetanovic, Meliha C, et al.
Publicado: (2014)

Rituximab in clinical practice: dosage, drug adherence, Ig levels, infections, and drug antibodies
por: Einarsson, Jon Thorkell, et al.
Publicado: (2017)

Integrin α2β1 Is a Receptor for the Cartilage Matrix Protein Chondroadherin
por: Camper, Lisbet, et al.
Publicado: (1997)

Cost-Effectiveness Analysis of Biopharmaceuticals for Treating Rheumatoid Arthritis: Infliximab, Adalimumab, and Etanercept
por: Gholami, Ahmad, et al.
Publicado: (2021)

Molecular events in cartilage formation and remodeling
por: Heinegård, Dick
Publicado: (2001)

Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis
por: Joosten, Leo AB, et al.
Publicado: (1999)

Joint remodeling outcome of serum levels of Dickkopf-1 (DKK1), cartilage oligomeric matrix protein (COMP), and C-telopeptide of type II collagen (CTXII) in rheumatoid arthritis
por: IDRISS, NAGLAA K., et al.
Publicado: (2020)

Effect of circadian rhythm, age, training and acute lameness on serum concentrations of cartilage oligomeric matrix protein (COMP) neo‐epitope in horses
por: Ekman, S., et al.
Publicado: (2019)

TGF-β Pathways Stratify Colorectal Cancer into Two Subtypes with Distinct Cartilage Oligomeric Matrix Protein (COMP) Expression-Related Characteristics
por: Ding, Jia-Tong, et al.
Publicado: (2022)

Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
por: Neovius, M, et al.
Publicado: (2015)

Cartilage Oligomeric Matrix Protein (COMP)-Mediated Cell Differentiation to Proteolysis Mechanism Networks from Human Normal Adjacent Tissues to Lung Adenocarcinoma
por: Wang, Lin, et al.
Publicado: (2013)

Incidental Finding of Elevated Serum Cartilage Oligomeric Matrix Protein (sCOMP) in Knee Osteoarthritis Patient with Undiagnosed Colon Cancer: A Case Report
por: Waluyo, Yose, et al.
Publicado: (2021)

Structure, evolution and expression of zebrafish cartilage oligomeric matrix protein (COMP, TSP5). CRISPR-Cas mutants show a dominant phenotype in myosepta
por: Forte-Gomez, Helena Fabiana, et al.
Publicado: (2022)

Antibodies to Cartilage Oligomeric Matrix Protein Are Pathogenic in Mice and May Be Clinically Relevant in Rheumatoid Arthritis
por: Ge, Changrong, et al.
Publicado: (2022)

Investigation of serum cartilage oligomer protein (COMP) levels in rheumatoid arthritis (RA)
por: Brozik, M, et al.
Publicado: (2002)

Additional effect of etanercept or infliximab on the liver function tests of patients with rheumatoid arthritis: a cohort study
por: Akhlaghi, Saeed, et al.
Publicado: (2018)

Review of Eight Pharmacoeconomic Studies of the Value of Biologic DMARDs Adalimumab, Etanercept, and Infliximab) in the Management of Rheumatoid Arthritis
por: Doan, Quan V., et al.
Publicado: (2006)

Cartilage oligomeric matrix protein specific antibodies are pathogenic
por: Geng, Hui, et al.
Publicado: (2012)

Cartilage Oligomeric Matrix Protein in Idiopathic Pulmonary Fibrosis
por: Vuga, Louis J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ev1ahkm6r679jifpvfrm2imlpv